JDRF and Gubra Join Forces to Develop a New Glucose Responsive Insulin for Diabetes
June 18, 2018
June 18, 2018
NEW YORK, June 18 -- JDRF, a charitable 501(c)(3) organization dedicated to funding type 1 diabetes research, issued the following news release:
JDRF and Gubra today announced a partnership to develop a glucose-responsive insulin (GRI) as a treatment for people with insulin-requiring diabetes, such as type 1 diabetes (T1D). The Gubra approach is based on a novel, and unique concept that differs fundamentally from other glucose sensing insulin approaches and the JDRF funding commitme . . .
JDRF and Gubra today announced a partnership to develop a glucose-responsive insulin (GRI) as a treatment for people with insulin-requiring diabetes, such as type 1 diabetes (T1D). The Gubra approach is based on a novel, and unique concept that differs fundamentally from other glucose sensing insulin approaches and the JDRF funding commitme . . .